Cyteir Therapeutics, Inc. (CYT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 58.2M |
| Enterprise Value | -88.03M |
| P/E Ratio | -2.42 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.73 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.81 |
| Fiscal Year | December 31, 2022 |
| Most Recent Quarter | September 30, 2023 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.29 |
| Return On Equity | -0.26 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.38M |
| EBITDA | -46.06M |
| Net Income | -43.95M |
| Diluted EPS | -1.25 |
| Total Cash | 129.24M |
| Total Cash/Share | 4.17 |
| Total Debt | 16,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 28.07 |
| Book Value Per Share | 4.15 |
| 52-Week Change | 55.68 |
| 52-Week High | 3.19 |
| 52-Week Low | 1.65 |
| Moving Average 50 Days | 3.09 |
| Moving Average 200 Days | 2.86 |
| Average Volume | 167,616 |
| Shares Outstanding | 36M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |